RT Journal Article SR Electronic T1 Clinical characteristics and Outcomes of 500 patients with COVID Pneumonia – Results from a Single center (Southend University Hospital) JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.08.13.20163030 DO 10.1101/2020.08.13.20163030 A1 Gouri Koduri A1 Sriya Gokaraju A1 Maria Darda A1 Vinod Warrier A1 Irina Duta A1 Fiona Hayes A1 Iman El Sayed A1 Yasser Ahmed YR 2020 UL http://medrxiv.org/content/early/2020/08/14/2020.08.13.20163030.abstract AB Objectives To characterise the clinical features of hospitalised COVID-19 patients in a single centre during the first epidemic wave and explore potential predictive variables associated with outcomes such as mortality and the need for mechanical ventilation, using baseline clinical parameters.Methodology We conducted a retrospective review of electronic records for demographic, clinical and laboratory data, imaging and outcomes for 500 hospitalised patients between February 20th and May 7th 2020 from Southend University Hospital, Essex, UK. Multivariate logistic regression models were used to identify risk factors relevant to outcome.Results The mean age of the cohort admitted to hospital with Covid-19, was 69.4 and 290 (58%) were over 70. The majority were Caucasians, 437 (87%) with ≤2 comorbidities 280(56%). Most common were hypertension 186(37%), Cardiovascular disease 178(36%) and Diabetes 128 (26%), represented in a larger proportion on the mortality group. Mean CFS was 4 with Non - Survivors had significantly higher CFS 5 vs 3 in survivors, p<0.001. In addition, Mean CRP was significantly higher 150 vs 90, p<0.001 in Non-Survivors. We observed the baseline predictors for mortality were age, CFS and CRP.Conclusions In this single centre study, older and frailer patients with more comorbidities and a higher baseline CRP and creatinine were risk factors for worse outcomes. Integrated frailty and age-based risk stratification are essential, in addition to monitoring SFR (Sp02/Fi02) and inflammatory markers throughout the disease course to allow for early intervention to improve patient outcomes.Competing Interest StatementDr SG, MD, VW, FH, ID and YA have nothing to disclose. Gouri Koduri reports research support from Roche outside the submitted work.Funding StatementNone recievedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a retrospective study on COVID Pneumonia which required data collection only. This study was conducted in accordance with the Institutional review board and approved by the Southend University Hospital NHS Foundation Trust and granted a waiver due to its retrospective observational designAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available at reasonable request